CEO Nicholas Curtis framed 2025 as a transition year after the terminated Alcon transaction, saying, “The termination of the acquisition agreement was a mutual pragmatic decision made after a year of ...

ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, ...

Sight Sciences Inc. (NASDAQ:SGHT) has obtained a court order confirming a jury’s finding that Alcon Inc. willfully infringed ...

Court preserves jury’s finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028MENLO PARK, Calif., March ...

Lensar Inc, a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, announced that it reached an agreement with Alcon Research, LLC (Alcon) to ...

Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More ...

Lensar is known for developing the Ally robotic cataract laser treatment system, alongside Streamline software technology and the Lensar legacy laser system. These technologies we ...

Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23.

Company to Report Fourth Quarter Financial Results and Provide Strategic Update on March 31, 2026ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company ...

GENEVA - Alcon (SIX/NYSE:ALC) terminated its merger agreement with LENSAR, Inc. (NASDAQ:LNSR) following opposition from the Federal Trade Commission, according to a press release statement Monday. The ...

We had a financial crisis in 2008, and while market moods are better than that these days, some analysts are starting to see some disturbing parallels. That’s the view of Goldman Sachs strategist ...